Risk Assessment in Scleroderma Patients With Newly Diagnosed Pulmonary Arterial Hypertension: Application of the ESC/ERS Risk Prediction Model

European Respiratory Journal - United Kingdom
doi 10.1183/13993003.00497-2018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Risk Assessment in Patients With Systemic Sclerosis and Pulmonary Arterial Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Pulmonary Arterial Hypertension Associated With Scleroderma

Advances in Pulmonary Hypertension
2008English

Preoperative Risk Assessment of Pulmonary Arterial Hypertension Patients Undergoing General Surgery

Advances in Pulmonary Hypertension
2007English

Prognostication in Pulmonary Arterial Hypertension and Use of Current Risk Prediction Models

Advances in Pulmonary Hypertension
2015English

Assessment of Pulmonary Arterial Hypertension (PAH) Risk in Sickle Cell Disease Patients Using Plasma Apolipoproteins

Science-Business eXchange
2008English

Scleroderma-Associated Pulmonary Hypertension: Who's at Risk and Why

Advances in Pulmonary Hypertension
2002English

Haemodynamics and Serial Risk Assessment in Systemic-Sclerosis Associated Pulmonary Arterial Hypertension

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2018English

Coronary Risk Stratification of Patients With Newly Diagnosed Heart Failure

Open Heart
Cardiovascular MedicineCardiology
2019English

Mortality-Related Risk Factors in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. The Importance of Response to Treatment

Open Journal of Respiratory Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy